Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.

Ran Nie,Zhou Wu,Junjun Ni,Fan Zeng,Weixian Yu,Yufeng Zhang,Tomoko Kadowaki,Haruhiko Kashiwazaki,Jessica L Teeling,Yanmin Zhou
DOI: https://doi.org/10.3233/JAD-190298
2019-01-01
Journal of Alzheimer s Disease
Abstract:Abnormal accumulation of amyloid-beta (A beta) in the brain is the most significant pathological hallmark of Alzheimer's disease (AD). We have found that chronic systemic exposure to lipopolysaccharide ofPorphyromonas gingivalis (P. gingivalis) induces the accumulation of A beta in the brain of middle-aged mice. On the other hand, recent research has shown that circulating A beta is transferred into the brain; however, the involvement of chronic systemic P. gingivalis infection in the peripheral A beta metabolism is unknown. We hypothesized that chronic P. gingivalis infection expands A beta pools in peripheral inflammatory tissues and thereby contributes to the accumulation of A beta in the brain of patients with periodontitis. We showed that the increased expression of IL-1 beta, A beta PP770, CatB, A beta(1-42), and A beta(3-42) was mainly co-localized with macrophages in the liver of P. gingivalis infected mice. Blocking CatB and NF-kappa B significantly inhibited the P. gingivalis-induced expression of IL-1 beta, A beta PP770, A beta(1-42), and A beta(3-42) in RAW264.7 cells. A beta(3-42), but not A beta(1-42), induced the significant death of macrophages, and the reduction of phagocytic abilities induced by A beta(3-42) tended to be higher than that induced by A beta(1-42). Additionally, the expression of A beta PP770, CatB, A beta(1-42), and A beta(3-42) was determined in the macrophages of gingival tissues from periodontitis patients. These findings indicate that chronic systemic P. gingivalis infection induces the A beta accumulation in inflammatory monocytes/macrophages via the activation of CatB/NF-kappa B signaling, thus suggesting monocytes/macrophages serve as a circulating pool of A beta in patients with periodontitis. Taken together, CatB may be a novel therapeutic target for preventing the periodontitis-related AD initiation and pathological progression.
What problem does this paper attempt to address?